SYLENTIS

Ophthalmologic preparations for the treatment of ocular disorders or diseases; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of ocular disorders or diseases; collyrium; ophthalmic preparations; medicated gels, creams and washing solutions for eye use; medicated eye drops; medicated eye lotions; medicated eye sprays; medicated eye ointments for treating dry eye, ocular pain and conjunctivitis; all the foregoing excluding those comprising isotopes or compounds labelled with stable isotopes

Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Development of pharmaceutical preparations and medicines; Pharmaceutical product evaluation; Research in the field of pharmaceuticals; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Development of pharmaceutical preparations and medicines for the treatment of eye diseases and conditions; Development of pharmaceutical preparations and medicines for the treatment of ocular disorders or diseases; Testing, inspection, research, or development of pharmaceutical preparations for the treatment of eye diseases and conditions; Testing, inspection, research, or development of pharmaceutical preparations for the treatment of ocular disorders or diseases; all the foregoing excluding isotope labelling and diagnostics